BIOXCEL THERAPEUTICS INC (BTAI) Institutional Shareholders
BIOXCEL THERAPEUTICS INC (BTAI) is currently reported in institutional portfolios tracked by InsiderSet based on the latest available SEC Form 13F filings for the quarter ended June 30, 2026. The institutional investors covered on this page collectively reported approximately $8.63M in BTAI holdings during the latest filing period.
Millennium Management Llc is currently the largest disclosed institutional shareholder of BTAI tracked by InsiderSet, reporting ownership valued at approximately $2.98M in its June 30, 2026 SEC Form 13F filing. Based on current market prices and the latest disclosed share count, the position is now estimated to be worth approximately $156,277.069, representing an estimated loss of -94.76% since the filing period.
The top 10 institutional shareholders tracked on this page collectively account for approximately 92% of the total disclosed BTAI value among the investors covered in this analysis. Major shareholders include Millennium Management Llc, Oaktree Capital Management, Vanguard Capital Management Llc, and several other long-term asset managers with concentrated positions in BIOXCEL THERAPEUTICS INC (BTAI).
This page ranks the largest institutional BTAI shareholders using publicly disclosed SEC Form 13F data, including reported values, estimated current holding values, portfolio allocation percentages, ownership concentration metrics, and historical holding changes across major hedge funds and investment firms.
Institutional Holders
44
Total Reported Value
$8.63M
Largest Holder
Millennium Management Llc
Largest Position
$2.98M
Insider Transactions (90d)
0
Latest Filing Quarter
Q2 2026
New Institutional Positions
57
Funds Exiting Positions
0
| Name | Investor/Manager | Portfolio % | Quantity | Reported Balance | Current Estimated Value | Gain/loss Since Filing | Estimated Portfolio Performance |
|---|---|---|---|---|---|---|---|
| Millennium Management Llc | 0.00% | 2,114,710 | $2,981,741 | $156,277 | -$2,825,464 | -94.76% | |
| Oaktree Capital Management | Howard Marks | 0.04% | 1,380,248 | $1,946,150 | $102,000 | -$1,844,150 | -94.76% |
| Vanguard Capital Management Llc | 0.00% | 919,545 | $1,296,558 | $67,954 | -$1,228,604 | -94.76% | |
| Oaktree Fund Advisors, Llc | 0.60% | 245,585 | $346,274 | $18,149 | -$328,125 | -94.76% | |
| Geode Capital Management, Llc | 0.00% | 242,251 | $341,911 | $17,902 | -$324,009 | -94.76% | |
| Blackrock, Inc. | 0.00% | 179,433 | $253,001 | $13,260 | -$239,741 | -94.76% | |
| Ubs Group Ag | 0.00% | 158,065 | $222,871 | $11,681 | -$211,190 | -94.76% | |
| Citadel Advisors Llc | 0.00% | 149,220 | $210,400 | $11,027 | -$199,373 | -94.76% | |
| Vanguard Fiduciary Trust Co | 0.00% | 136,937 | $193,081 | $10,120 | -$182,961 | -94.76% | |
| State Street Corp | 0.00% | 92,118 | $129,886 | $6,808 | -$123,078 | -94.76% | |
| Fmr Llc | 0.00% | 90,300 | $127,323 | $6,673 | -$120,650 | -94.76% | |
| &Partners | 0.00% | 83,588 | $117,859 | $6,177 | -$111,682 | -94.76% | |
| Jones Financial Companies Lllp | 0.00% | 63,139 | $82,712 | $4,666 | -$78,046 | -94.36% | |
| Northern Trust Corp | 0.00% | 56,318 | $79,408 | $4,162 | -$75,246 | -94.76% | |
| Quadrature Capital Ltd | 0.00% | 38,038 | $53,634 | $2,811 | -$50,823 | -94.76% | |
| Headlands Technologies Llc | 0.00% | 25,556 | $36,034 | $1,889 | -$34,145 | -94.76% | |
| Stonex Group Inc. | 0.00% | 20,684 | $29,164 | $1,529 | -$27,635 | -94.76% | |
| Beacon Pointe Advisors, Llc | 0.00% | 18,837 | $26,561 | $1,392 | -$25,169 | -94.76% | |
| Susquehanna International Group, Llp | 0.00% | 17,200 | $24,252 | $1,271 | -$22,981 | -94.76% | |
| Portfolio Strategies, Inc. | 0.00% | 16,831 | $23,732 | $1,244 | -$22,488 | -94.76% | |
| Virtu Financial Llc | 0.00% | 15,967 | $23,000 | $1,180 | -$21,820 | -94.87% | |
| Osaic Holdings, Inc. | 0.00% | 16,214 | $22,860 | $1,198 | -$21,662 | -94.76% | |
| Two Sigma Securities, Llc | 0.00% | 10,796 | $15,222 | $798 | -$14,424 | -94.76% | |
| Diversify Advisory Services, Llc | 0.00% | 15,000 | $13,005 | $1,109 | -$11,897 | -91.48% | |
| Diversify Wealth Management, Llc | 0.00% | 15,000 | $13,005 | $1,109 | -$11,897 | -91.48% | |
| Wells Fargo & Company/Mn | 0.00% | 4,337 | $6,115 | $321 | -$5,794 | -94.76% | |
| Citigroup Inc | 0.00% | 2,998 | $4,227 | $222 | -$4,005 | -94.76% | |
| Morgan Stanley | 0.00% | 1,671 | $2,356 | $123 | -$2,233 | -94.76% | |
| Barclays Plc | 0.00% | 1,428 | $2,013 | $106 | -$1,907 | -94.76% | |
| Newedge Advisors, Llc | 0.00% | 1,331 | $1,877 | $98 | -$1,779 | -94.76% | |
| Vanguard Global Advisers, Llc | 0.00% | 493 | $695 | $36 | -$659 | -94.76% | |
| Silver Grove Financial Group, Inc. | 0.00% | 331 | $468 | $24 | -$444 | -94.77% | |
| Tower Research Capital Llc (Trc) | 0.00% | 227 | $320 | $17 | -$303 | -94.76% | |
| Parkside Financial Bank & Trust | 0.00% | 112 | $158 | $8 | -$150 | -94.76% | |
| Washington Trust Advisors, Inc. | 0.00% | 82 | $116 | $6 | -$110 | -94.78% | |
| Jpmorgan Chase & Co | 0.00% | 45 | $63 | $3 | -$60 | -94.72% | |
| Farther Finance Advisors, Llc | 0.00% | 25 | $35 | $2 | -$33 | -94.72% | |
| Ifp Advisors, Inc | 0.00% | 13 | $18 | $1 | -$17 | -94.66% | |
| Sbi Securities Co., Ltd. | 0.00% | 13 | $18 | $1 | -$17 | -94.66% | |
| Bnp Paribas Financial Markets | 0.00% | 12 | $17 | $1 | -$16 | -94.78% | |
| Zurcher Kantonalbank (Zurich Cantonalbank) | 0.00% | 2 | $3 | $0 | -$3 | -95.07% | |
| Group One Trading Llc | 0.00% | 1 | $1 | $0 | -$1 | -92.61% | |
| Triumph Capital Management | 0.00% | 1 | $1 | $0 | -$1 | -92.61% | |
| Us Bancorp \De\ | 0.00% | 1 | $1 | $0 | -$1 | -92.61% |
Frequently asked questions about BTAI
Who owns the most BTAI stock?
The largest holders of BTAI are typically major institutional investors such as asset managers and hedge funds reporting on Form 13F. The table above ranks tracked superinvestors by reported position size using the latest available filings for BIOXCEL THERAPEUTICS INC (BTAI).
Is BTAI widely held by superinvestors?
Many widely followed stocks like BTAI appear across numerous superinvestor portfolios because of liquidity, index inclusion, and fundamentals. The holder count and table above show how broadly BTAI is represented among the institutional managers we track.
What do “Current Estimated Value”, “Gain/loss Since Filing”, and “Estimated Portfolio Performance” mean?
Current Estimated Value is reported share quantity from the latest 13F times our most recent split-adjusted U.S. session close. Gain/loss Since Filing is that estimate minus the reported 13F dollar value; Estimated Portfolio Performance is that difference as a percent of the reported value. Green means the estimate is above the filing value; red means below (not purchase cost). If many filers share the same implied filing price per share, the performance % may match across rows. These are not official fund marks or live quotes.